ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625499 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625499; 2) Community: the network communities that were significantly associated with the response to NSC 625499; 3) Molecule: the relationships between components within communities and NSC 625499; 4) MDR: the compounds that were significantly associated with the NSC 625499.

NSC Compound Enrichment Correlation
NSC 687011 stereoisomer of 672120 (MW=262) 0.000649370174092108 0.46924022
NSC 680827 Null 0.000839001373926613 0.049880485
NSC 711104 Null 0.000839001373926613 -0.17956595
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.000839001373926613 0.36948071
NSC 335663 ACETYLROLANDROLIDE 0.00107960355103008 0.54558505
NSC 694000 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester 0.00107960355103009 0.27611477
NSC 698408 Null 0.00107960355103009 0.28232218
NSC 756134 GSK1023156A 0.00107960355103009 0.43454852
NSC 764037 BP-1-102 0.00107960355103009 0.31255503
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0013655184802855 0.58760345
Total:74  Current:2    [First] [Prev] [Next] [Last]